Sep 1, 2026 09:07AM
Aug 10, 2026 09:01AM
Aug 10, 2026 09:00AM
Aug 4, 2026 07:30AM
Jul 30, 2026 04:53AM
Jul 29, 2026 06:45PM
Jun 1, 2026 01:53PM ImmunityBio to present cancer drug data at ASCO 2026 meeting
Jun 1, 2026 01:51PM
May 21, 2026 04:28PM
May 20, 2026 02:18PM
May 19, 2026 08:30PM
May 19, 2026 08:30PM
May 19, 2026 02:16PM
May 19, 2026 07:31AM ImmunityBio presents bladder cancer treatment comparison data at AUA
May 19, 2026 07:30AM
May 18, 2026 01:01PM
May 18, 2026 07:31AM
May 18, 2026 07:30AM
May 16, 2026 01:35PM
May 16, 2026 01:35PM
May 7, 2026 09:00AM IBRX Lawsuit Alleges Company Allegedly Violated FDA Drug Rules - ImmunityBio Investors Face Losses Following Company Allegedly Violated FDA Drug Rules: SueWallSt
May 7, 2026 07:30AM
Apr 6, 2026 07:30AM
Apr 6, 2026 07:30AM
Mar 31, 2026 07:31AM
Mar 31, 2026 07:30AM
Mar 26, 2026 07:30AM
Mar 26, 2026 07:30AM ImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBC Trial to Detect Clinically Meaningful Differences Between ANKTIVA® Plus BCG Versus BCG Alone; Supplemental BLA Submission
Mar 24, 2026 12:52PM
Mar 24, 2026 10:44AM
Mar 24, 2026 09:27AM
Mar 20, 2026 01:08PM
Mar 20, 2026 01:08PM
Mar 17, 2026 07:31AM
Mar 17, 2026 07:30AM ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIBC With Papillary-Only Disease
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM
Mar 4, 2026 07:54AM
Feb 26, 2026 07:31AM
Feb 26, 2026 07:30AM
Feb 23, 2026 04:15PM
Feb 23, 2026 09:36AM Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
Feb 23, 2026 07:01AM
Feb 23, 2026 07:00AM
Feb 20, 2026 08:30AM
Feb 20, 2026 08:30AM
Feb 19, 2026 09:02AM
Feb 19, 2026 09:00AM
Feb 18, 2026 09:01AM ImmunityBio wins European approval for bladder cancer treatment
Feb 18, 2026 09:00AM

329,914 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All